Skip to main content

Military Health System

New COVID-19 Delta Variant: What You Need to Know to Stay Safe

Image of Military personnel receiving the COVID-19 vaccine. Military personnel receiving the COVID-19 vaccine

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

A new and increasingly dangerous variant of the SARS-CoV-2 virus is rapidly sweeping across the globe. This new variant appears to spread faster, cause more severe disease and is more likely to result in hospitalization.

Also, younger people appear to be more susceptible to the new strain, known as the Delta variant, according to the Centers for Disease Control and Prevention (CDC).

But the good news is that the existing vaccines now available to everyone over the age of 12 have proven to be highly effective in preventing the Delta variant as well as other versions of COVID-19.

"We know that vaccines work," said Dr. Margaret Ryan, medical director of the Defense Health Agency's Immunization Healthcare Division.

Currently, there are three vaccines authorized for use by the Food and Drug Administration for COVID-19: The Pfizer and Moderna mRNA vaccines require two doses, and J&J/Janssen is a one-dose vaccine.

The Delta variant is spreading quickly and will likely soon become the dominant strain within the United States.

It's a wake-up call for those people who think that they don't need to get a vaccine because they've successfully avoided the COVID-19 disease so far. It may be very difficult to escape the new Delta variant in the coming months without getting the shot, doctors say.

The Delta variant currently accounts for 20.6 percent of sequenced cases in the U.S., and that number is expected to multiply, especially in regions and among populations with low COVID-19 vaccination rates.

The number of sequenced cases of the Delta variant has roughly doubled every two weeks, Dr. Anthony Fauci, chief medical advisor to President Joe Biden, told a June 22 White House media briefing. Fauci is director of the National Institute of Allergy and Infectious Disease at the National Institutes of Health.

The mRNA vaccines made by Pfizer and Moderna have been described as having at least 88 percent efficacy against the Delta variant of SARS-CoV-2, Ryan said.

"But we should not focus too hard on efficacy numbers," she suggested. "All available COVID-19 vaccines have shown strong real-world effectiveness at preventing severe disease by all COVID-19 variants. The most important message is that vaccination saves lives."

Vaccination is also important to prevent new, possibly worse, variants of the virus from appearing, Ryan said. "Every person who gets infected with SARS-CoV-2 allows the virus to replicate, or copy itself, up to one billion times. Every time the virus copies itself, there is a chance for a new variant to appear. We prevent variants from appearing by preventing human infections. We prevent human infections by vaccination," she said.

Because of the Delta variant, “Everyone in the U.S. who is at least 12 years old should be fully vaccinated with a COVID-19 vaccine as soon as possible," Ryan said.

More than half of the U.S. population has received at least one dose of a COVID-19 vaccine; and 150.4 million, or 45.3 percent are fully vaccinated. For those over the age of 65, 87.3 percent have had at least one dose; 77.2 percent are fully vaccinated.

You also may be interested in...

Tiered Telehealth Health Care Support for COVID-19

Publication
3/31/2020

This memorandum establishes guidance for the use of Telehealth (TH) Information Technology (IT) tools in support of the clinical care required for patients across the spectrum of COVID-19 illness

Recommended Content:

Information for Patients: About TRICARE | Public Health | Coronavirus & the MHS Response

MHS Minute Combatting COVID 19

Video
3/30/2020
The MHS Minute, Special Edition: COVID-19

Agencies across the federal government are partnering up to combat COVID-19. Find out how the Military Health System is doing its part to support the U.S. response to this pandemic, while ensuring our Service members remain ready.

Recommended Content:

Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine

Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Communication to ABA Providers Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Recommended Content:

Coronavirus & the MHS Response | Information for Patients: About TRICARE

Q & A: Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Question and Answer: TRICARE Autism Care Demonstration (ACD): Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 during the COVID-19 National Emergency

Recommended Content:

Coronavirus & the MHS Response | Information for Patients: About TRICARE

COVID-19 Life Support Training Extension

Publication
3/19/2020

The purpose of this memorandum is to set policy guidance within the Military Health System for American Red Cross life support training (First Aid/cardiopulmonary resuscitation (CPR)/automated external defibrillator (AED), Basic Life Support (BLS), Advanced Life Support (ALS), and Pediatric Advanced Life Support (PALS)).

Recommended Content:

Coronavirus & the MHS Response

Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform

Congressional Testimony
3/11/2020

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response

MHS GENESIS Patient Portal Fact Sheet

Fact Sheet
7/30/2019

This fact sheet describes the MHS GENESIS Patient Portal.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | MHS GENESIS Pre-Deployment Awareness
<< < ... 31 > >> 
Showing results 451 - 457 Page 31 of 31
Refine your search
Last Updated: January 24, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery